MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MANDEL, L. R.
Right arrow Articles by CRAGOE, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MANDEL, L. R.
Right arrow Articles by CRAGOE, E. J., JR.

Molecular Pharmacology, Vol 14, 930-939, Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics

Inhibition of Dimethyltryptamine Biosynthesis by N,N'-Bis-(3-methyl-2-thiazolidinylidene)Succinamide (I) and 2-Imino-3-Methylthiazolidine (II)

LEWIS R. MANDEL 1, JOSHUA ROKACH 1, C. STANLEY ROONEY 1, and EDWARD J. CRAGOE JR. 1

1 Merck Sharp & Dohme Research Laboratories, Rahway, New Jersey 07065, West Point, Pennsylvania 19486, and Dorval, Quebec, Canada H9R4P8

N,N'-bis-(3-methyl-2-thiazolidinylidene)succinamide (I) and 2-imino-3-methylthiazolidine (II) are inhibitors of indoleamine-N-methyltransferase, the enzyme which biosynthesizes N,N-dimethyltryptamine. I was designed as a neutral compound which will form the active basic metabolite II in rabbits. In Vitro, I is not an effective inhibitor, while II is a potent inhibitor of the rabbit and human lung enzyme (IC50 le 3 µM). When administered to rabbits at 4-5 mg/kg i.v., both compounds produce a 60% reduction in the specific activity of the lung methyltransferase. A single oral dose of I produces 50% inhibition of enzyme activity when the animals are sacrificed 2 hr after dosage (8 mg/kg) or at 7 hr (68 mg/kg). Administration of II in the drinking water for 12 days at a daily dose equivalent to about 7 mg/kg results in a 36% inhibition in the activity of the lung enzyme. When enzyme preparations from drug-treated rabbits were dialyzed, the specific activity returned to control values, suggesting a reversible type inhibition. I was also evaluated orally for its effect on dimethyltryptamine biosynthesis in rabbits; at single doses of 100 mg/kg or at 25 mg/kg twice daily for four days, there was a 65% reduction in the conversion of [14C]N-methyltryptamine (administered i.v.) to [14C]dimethyltryptamine in lung. The level of carotid arterial DMT appearing over 1 minute after the intravenous injection of NMT (10 mg/kg) was also reduced 75%. Thus, inhibition of indoleamine-N-methyltransferase results in a block in the in vivo biosynthesis of dimethyltryptamine.

Note:
ACKNOWLEDGMENTS The authors are grateful to Dr. R. A. Prasad, Dr. T. Farver, Dr. A. G. Zacchei, Mr. M. Schnall, Mr. R. W. Walker and Mr. B. Lopez-Ramos for valuable assistance on various aspects of this work. We also thank Dr. A. Rosegay and Dr. H. Mertel for the synthesis of the [14C]NMT, and Dr. Duggan for advice on preparing the manuscript.

Submitted on January 10, 1978
Accepted on April 17, 1978







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics